Basic Information
Basic information for LINC01010-211-41aa-1
Peptide Name LINC01010-211-41aa-1
Genome Position chr6:134503642-134503764[+]
Species Human
Peptide Sequence MGSPSRTLIESSDHQECPTKSLPLLVTRACFPWRAPEGRKL
Peptide Length 41
Unique No (LINC01010-201-41aa-1,LINC01010-202-41aa-2,LINC01010-203-41aa-1,LINC01010-204-41aa-1,LINC01010-205-41aa-1,LINC01010-206-41aa-2,LINC01010-207-41aa-1,LINC01010-208-41aa-2,LINC01010-209-41aa-1,LINC01010-210-41aa-2,LINC01010-212-41aa-1,LINC01010-213-41aa-2,LINC01010-214-41aa-1,LINC01010-215-41aa-1,LINC01010-216-41aa-1)
Grand Average of Hydropathicity -0.5195
Relative Molecular Mass 5316.99
Experimental Evidences 2:m6A,ribo
lncRNA ID/Name ENSG00000236700;LINC01010
Transcript ID/Name ENST00000661139;LINC01010-211
Transcript Length 1471
Coding Ability 0.4494
DNA Sequence Corresponding to Peptide ATGGGCTCACCCTCTAGGACCCTGATTGAGTCCTCGGACCACCAAGAGTGCCCCACCAAGAGCCTCCCTCTTCTGGTGACTCGTGCCTGCTTCCCGTGGAGAGCTCCAGAAGGGAGGAAACTG
Experimental Evidences
   m6A
   Occupancy of Ribosomes
Tissue :    
Expression type:    Count RPKM
Conservation
   Conservation
Peptide-MHC I binding
   Peptide-MHC I binding
Peptide-MHC II binding
   Peptide-MHC II binding
Spatial Expression
   Spatial Expression
Source :   
Clinical Relevance
   Clinical Relevance
Source :   
Cancer :